Princess Máxima Center for pediatric Oncology, Utrecht, The Netherlands.
Faculty of Medicine, Department of Paediatrics, Lund University, Lund, Sweden.
BMC Cancer. 2023 Sep 11;23(1):855. doi: 10.1186/s12885-023-11379-z.
Comprehensive insight in the longitudinal development of health-related quality of life (HRQOL) after childhood cancer diagnosis could improve quality of care. Thus, we aimed to study the course and biopsychosocial determinants of HRQOL in a unique national cohort of children with cancer.
HRQOL of 2154 children with cancer was longitudinally reported (median: 3 reports) between diagnosis and 5 years after, using the pediatric quality of life inventory generic core scales (PedsQL). HRQOL was modelled over time since diagnosis using mixed model analysis for children 2-7 years (caregiver-reports) and ≥ 8 years (self-reports). Differences in the course between hematological, solid and central nervous system malignancies were studied. Additional associations of demographics, disease characteristics (age at diagnosis, relapse, diagnosis after the national centralization of childhood cancer care and treatment components) and caregiver distress (Distress thermometer) were studied.
Overall, HRQOL improved with time since diagnosis, mostly in the first years. The course of HRQOL differed between diagnostic groups. In children aged 2-7 years, children with a solid tumor had most favorable HRQOL. In children aged ≥ 8 years, those with a hematological malignancy had lower HRQOL around diagnosis, but stronger improvement over time than the other diagnostic groups. In both age-groups, the course of HRQOL of children with a CNS tumor showed little or no improvement. Small to moderate associations (β: 0.18 to 0.67, p < 0.05) with disease characteristics were found. Centralized care related to better HRQOL (β: 0.25 to 0.44, p < 0.05). Caregiver distress was most consistently associated with worse HRQOL (β: - 0.13 to - 0.48, p < 0.01).
The HRQOL course presented can aid in identifying children who have not fully recovered their HRQOL following cancer diagnosis, enabling early recognition of the issue. Future research should focus on ways to support children, especially those with a CNS tumor, for example by decreasing distress in their caregivers.
全面了解儿童癌症诊断后健康相关生活质量(HRQOL)的纵向发展情况,可以提高护理质量。因此,我们旨在通过对独特的国家儿童癌症队列进行研究,来探索 HRQOL 的发展轨迹和生物心理社会决定因素。
使用儿童生活质量量表通用核心量表(PedsQL),对 2154 名癌症患儿进行了纵向报告(中位数:3 次报告),从诊断开始到 5 年后。使用混合模型分析,对 2-7 岁的儿童(由照顾者报告)和≥8 岁的儿童(自我报告),对诊断后时间的 HRQOL 进行了建模。研究了血液系统恶性肿瘤、实体瘤和中枢神经系统恶性肿瘤之间的差异。还研究了人口统计学、疾病特征(诊断时的年龄、复发、国家儿童癌症治疗集中化后的诊断和治疗部分)和照顾者痛苦(痛苦温度计)与 HRQOL 之间的相关性。
总体而言,HRQOL 随诊断后时间的推移而改善,主要是在最初的几年。HRQOL 的发展轨迹因诊断组而异。在 2-7 岁的儿童中,患有实体瘤的儿童 HRQOL 最佳。在≥8 岁的儿童中,患有血液系统恶性肿瘤的儿童在诊断时的 HRQOL 较低,但随着时间的推移,他们的改善程度强于其他诊断组。在这两个年龄组中,中枢神经系统肿瘤患儿的 HRQOL 改善很小或没有改善。发现疾病特征与 HRQOL 之间存在小到中度的关联(β:0.18 至 0.67,p<0.05)。集中治疗与更好的 HRQOL 相关(β:0.25 至 0.44,p<0.05)。照顾者的痛苦与更差的 HRQOL 最密切相关(β:-0.13 至-0.48,p<0.01)。
本研究提供的 HRQOL 发展轨迹有助于识别癌症诊断后尚未完全恢复 HRQOL 的儿童,从而早期发现问题。未来的研究应重点关注如何支持儿童,尤其是患有中枢神经系统肿瘤的儿童,例如通过减少其照顾者的痛苦。